184 related articles for article (PubMed ID: 284840)
1. Methotrexate and asparaginase combination chemotherapy in refractory acute lymphoblastic leukemia of childhood.
Lobel JS; O'Brien RT; McIntosh S; Aspnes GT; Capizzi RL
Cancer; 1979 Mar; 43(3):1089-94. PubMed ID: 284840
[TBL] [Abstract][Full Text] [Related]
2. Sequential combination of methotrexate and L-asparaginase in the treatment of refractory acute leukemia.
Amadori S; Tribalto M; Pacilli L; De Laurentis C; Papa G; Mandelli F
Cancer Treat Rep; 1980; 64(8-9):939-42. PubMed ID: 6934851
[TBL] [Abstract][Full Text] [Related]
3. Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adults.
Yap BS; McCredie KB; Keating MJ; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65 Suppl 1():83-7. PubMed ID: 6948610
[TBL] [Abstract][Full Text] [Related]
4. Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cells.
Capizzi RL
Cancer Treat Rep; 1981; 65 Suppl 4():115-21. PubMed ID: 7049375
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate/L-asparaginase combination chemotherapy for patients with acute leukemia in relapse: a study of 36 children.
Harris RE; McCallister JA; Provisor DS; Weetman RM; Baehner RL
Cancer; 1980 Nov; 46(9):2004-8. PubMed ID: 6968621
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate plus L-asparaginase. An active combination for children with acute nonlymphocytic leukemia.
Hudson MM; Dahl GV; Kalwinsky DK; Pui CH
Cancer; 1990 Jun; 65(12):2615-8. PubMed ID: 2340462
[TBL] [Abstract][Full Text] [Related]
7. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study.
Sullivan MP; Chen T; Dyment PG; Hvizdala E; Steuber CP
Blood; 1982 Oct; 60(4):948-58. PubMed ID: 6956376
[TBL] [Abstract][Full Text] [Related]
8. Refractory acute leukaemia in adults treated with sequential colaspase and high-dose methotrexate.
Yap BS; McCredie KB; Benjamin RS; Bodey GP; Freireich EJ
Br Med J; 1978 Sep; 2(6140):791-3. PubMed ID: 279387
[TBL] [Abstract][Full Text] [Related]
9. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
Winick N; Shuster JJ; Bowman WP; Borowitz M; Farrow A; Jacaruso D; Buchanan GR; Kamen BA
J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342
[TBL] [Abstract][Full Text] [Related]
10. Prolonged second remissions in childhood acute lymphocytic leukemia: a report from the Childrens Cancer Study Group.
Baum E; Nachman J; Ramsay N; Weetman B; Neerhout R; Littman P; Griffin T; Norris D; Sather H
Med Pediatr Oncol; 1983; 11(1):1-7. PubMed ID: 6572777
[TBL] [Abstract][Full Text] [Related]
11. Sequential administration of methotrexate and asparaginase in relapsed or refractory pediatric acute myeloid leukemia.
Buaboonnam J; Cao X; Pauley JL; Pui CH; Ribeiro RC; Rubnitz JE; Inaba H
Pediatr Blood Cancer; 2013 Jul; 60(7):1161-4. PubMed ID: 23335430
[TBL] [Abstract][Full Text] [Related]
12. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.
Clavell LA; Gelber RD; Cohen HJ; Hitchcock-Bryan S; Cassady JR; Tarbell NJ; Blattner SR; Tantravahi R; Leavitt P; Sallan SE
N Engl J Med; 1986 Sep; 315(11):657-63. PubMed ID: 2943992
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapy.
Haghbin M; Tan CT; Clarkson BD; Miké V; Burchenal JH; Murphy ML
Cancer Res; 1975 Mar; 35(3):807-11. PubMed ID: 1054287
[TBL] [Abstract][Full Text] [Related]
14. Therapy of refractory adult acute lymphoblastic leukemia with vincristine and prednisone plus tandem methotrexate and L-asparaginase. Results of a Cancer and Leukemia Group B Study.
Terebelo HR; Anderson K; Wiernik PH; Cuttner J; Cooper RM; Faso L; Berenberg JL
Am J Clin Oncol; 1986 Oct; 9(5):411-5. PubMed ID: 3465228
[TBL] [Abstract][Full Text] [Related]
15. Preliminary results of the combination methotrexate-asparaginase in patients with acute non lymphoid leukemia.
Mandelli F; Amadori S; Pacilli L; Tribalto M
Biomedicine; 1978 Jun; 29(4):116-7. PubMed ID: 687752
[TBL] [Abstract][Full Text] [Related]
16. Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group.
Ertel IJ; Nesbit ME; Hammond D; Weiner J; Sather H
Cancer Res; 1979 Oct; 39(10):3893-6. PubMed ID: 383278
[TBL] [Abstract][Full Text] [Related]
17. L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone.
Smithson WA; Gilchrist GS; Burgert EO
Med Pediatr Oncol; 1979; 6(2):163-70. PubMed ID: 287856
[TBL] [Abstract][Full Text] [Related]
18. Modified Capizzi maintenance regimen in children with relapsed acute lymphoblastic leukaemia.
Pinkerton CR; Mills S; Chessells JM
Med Pediatr Oncol; 1986; 14(2):69-72. PubMed ID: 3458998
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia.
Wolfrom C; Hartmann R; Fengler R; Brühmüller S; Ingwersen A; Henze G
J Clin Oncol; 1993 May; 11(5):827-33. PubMed ID: 8487046
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
Lange BJ; Blatt J; Sather HN; Meadows AT
Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
